Comparison of Fixation Suture Type in Glaucoma Surgery

Sponsor
Medical University of Bialystok (Other)
Overall Status
Completed
CT.gov ID
NCT03797846
Collaborator
(none)
41
1
2
17
2.4

Study Details

Study Description

Brief Summary

The aim of the study is to compare the effectiveness and safety of two types of intraoperative eye fixation: for the superior rectus muscle and traction suture in the peripheral cornea.

This is a prospective randomized trial with a 6 month follow-up period, which covers patients with open angle glaucoma qualified for combined glaucoma procedure (phacotrabeculectomy). In I group, the intraoperatively fixation in the peripheral part of the cornea is used, in II group the bridle suture for the superior rectus muscle is performed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: combined glaucoma surgery
N/A

Detailed Description

The way of the intraoperatively fixation may have some impact for postoperative results of the level of intraocular pressure (IOP), visual acuity (BCVA) and the incidence of upper eyelid ptosis was determined as a post-operative MRD (margin reflex distance) ≥2mm.

Study Design

Study Type:
Interventional
Actual Enrollment :
41 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A prospective randomized trial with a 6 month follow-up periodA prospective randomized trial with a 6 month follow-up period
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Effectiveness and Safety of Eye Fixation Types During Combined Glaucoma Procedures
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Jan 1, 2019
Actual Study Completion Date :
Jun 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Corneal Suture

intraoperative fixation with the suture in clear cornea qualified to the combined glaucoma surgery

Procedure: combined glaucoma surgery
combined procedure with trabeculectomy and cataract removal

Active Comparator: Muscle Suture

intraoperative fixation with the bridle suture for superior rectus muscle qualified to the combined glaucoma surgery

Procedure: combined glaucoma surgery
combined procedure with trabeculectomy and cataract removal

Outcome Measures

Primary Outcome Measures

  1. IOP [baseline and twelve months after surgery]

    the change in the level of intraocular pressure

Secondary Outcome Measures

  1. BCVA [baseline and twelve months after surgery]

    the change in the best corrected visual acuity

  2. MRD [baseline and twelve months after surgery]

    the incidence of upper eyelid ptosis determined as a post-operative MRD (margin reflex distance) ≥2mm

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • co-existing glaucoma and cataract (NC1, NC2) classified by means of the LOCS III scale (Lens Opacities Classification System III)

  • primary open-angle glaucoma and secondary pseudoexfoliative glaucoma, in which a satisfactory IOP level was not achieved despite maximum tolerable hypotensive treatment, both topical and systemic

  • documented progression of loss of field of vision

  • significant daily IOP fluctuations

  • no cooperation from patient with regard to application of anti-glaucoma treatment, allergy to topical medications

Exclusion Criteria:
  • no consent to participation in the study

  • prior surgical and laser procedures in the area of the eye

  • narrow- or closed-angle glaucoma

  • post-inflammatory or post-traumatic secondary glaucoma

  • chronic illness of the cornea or optic nerve

  • advanced macular degeneration

  • active inflammatory process

  • pregnancy

  • systemic steroid therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University Białystok Poland 15-089

Sponsors and Collaborators

  • Medical University of Bialystok

Investigators

  • Study Chair: Zofia Mariak, Prof, Medical University of Bialystok

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Joanna Konopińska, MD, PhD, Medical University of Bialystok
ClinicalTrials.gov Identifier:
NCT03797846
Other Study ID Numbers:
  • 1771
First Posted:
Jan 9, 2019
Last Update Posted:
Jul 14, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joanna Konopińska, MD, PhD, Medical University of Bialystok
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 14, 2020